Evidence map›Paper›PMID 38003315›Full record

ArticleInternational journal of molecular sciences2023

Nanoparticles Based on Silver Chloride and Bambusuril[6] for the Fine-Tuning of Biological Activity.

Pana Turebayeva, Venera Luchsheva, Dmitriy Fedorishin, Rakhmetulla Yerkassov, Abdigali Bakibaev, Saltanat Bolysbekova, Tokzhan Tugambayeva, Samal Sergazina, Nurgul Nurmukhanbetova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pana TurebayevaDepartment of Chemistry, L.N. Gumilyov Eurasian National University, 010000 Astana, Kazakhstan.ORCID 0000-0002-3278-1214
Venera LuchshevaFaculty of Chemistry, National Research Tomsk State University, 634050 Tomsk, Russia.ORCID 0000-0003-3742-6243
Dmitriy FedorishinFaculty of Chemistry, National Research Tomsk State University, 634050 Tomsk, Russia.ORCID 0000-0001-9492-536X
Rakhmetulla YerkassovDepartment of Chemistry, L.N. Gumilyov Eurasian National University, 010000 Astana, Kazakhstan.
Abdigali BakibaevFaculty of Chemistry, National Research Tomsk State University, 634050 Tomsk, Russia.
Saltanat BolysbekovaHigher School of Scientific Research, Astana International University, 010000 Astana, Kazakhstan.ORCID 0000-0002-5300-553X
Tokzhan TugambayevaDepartment of Chemistry and Chemical Technologies, Toraighyrov University, 140008 Pavlodar, Kazakhstan.
Samal SergazinaDepartment of Chemistry and Biotechnology, Sh. Ualikhanov University, 020000 Kokshetau, Kazakhstan.ORCID 0000-0001-9764-6729
Nurgul NurmukhanbetovaDepartment of Chemistry and Biotechnology, Sh. Ualikhanov University, 020000 Kokshetau, Kazakhstan.ORCID 0000-0002-0595-3535

Funding

CSRD VA 1
6 · The paper itself

Abstract

The prevalence of numerous infectious diseases has emerged as a grave concern within the realm of healthcare. Currently, the issue of antibiotic resistance is compelling scientists to explore novel treatment approaches. To combat these infectious diseases, various treatment methods have been developed, harnessing cutting-edge disinfecting nanomaterials. Among the range of metallic nanoparticles employed in medicine, silver nanoparticles (AgNPs) stand out as both highly popular and well-suited for the task. They find extensive utility in cancer diagnosis and therapies and as effective antibacterial agents. The interaction between silver and bacterial cells induces significant structural and morphological alterations, ultimately leading to cell demise. In this study, nanoparticles based on silver and bambusuril[6] (BU[6]) were developed for the first time. These NPs can be used for different biomedical purposes. A simple, single-step, and effective synthesis method was employed to produce bambusuril[6]-protected silver chloride nanoparticles (BU[6]-Ag/AgCl NPs) through the complexation of BU[6] with silver nitrate. The NPs were characterized using X-ray phase analysis (XPS), infrared spectroscopy (IR), thermogravimetric analysis (TGA), scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS). When the SEM images were examined, it was seen that the synthesized BU[6]-Ag/AgCl NPs were distributed with homogeneous sizes, and the synthesized NPs were mostly spherical and cubic. The EDS spectra of BU[6]-Ag/AgCl NPs demonstrated the presence of Ag, Cl, and all expected elements. BU[6]-Ag/AgCl NPs showed high antibacterial activity against both

Indexed as

Communicable DiseasesMetal NanoparticlesAnti-Bacterial AgentsEscherichia coliHumansSilverSilver CompoundsSpectroscopy, Fourier Transform InfraredStaphylococcus aureusAnti-Bacterial AgentsSilversilver chlorideSilver Compoundsantibacterial activitybambusuril[6]MTT-testsilver chloride nanoparticlessupramolecular chemistrythermal analysis

Identifiers

PMID38003315
PMCPMC10670921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.